Title : Sunitinib treatment promotes metastasis of drug-resistant renal cell carcinoma via TFE3 signaling pathway.

Pub. Date : 2021 Feb 26

PMID : 33637706






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Receptor tyrosine kinase (RTK) inhibitors, such as sunitinib and sorafenib, remain the first-line drugs for the treatment of mRCC. sorafenib ret proto-oncogene Homo sapiens
2 Receptor tyrosine kinase (RTK) inhibitors, such as sunitinib and sorafenib, remain the first-line drugs for the treatment of mRCC. sorafenib ret proto-oncogene Homo sapiens